AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca is conducting a Phase I study titled ‘A Phase ...

AstraZeneca PLC is rated a Buy due to strong growth, prudent R&D reinvestment, low leverage and resilience. Learn more about ...

AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca recently completed a Phase 1b study titled A ...

At this year's ASH congress, the results of the phase 1b/2 DURGA-1 of AZD0120 – a dual BCMA and CD19-directed CAR-T therapy – ...

Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to ...

The pharmaceutical company AstraZeneca can move forward with an addition to one of the buildings on its Frederick campus, ...

The move would onshore production of its rare disease products at an existing facility in Frederick and build a clinical ...

British pharma major AstraZeneca (LSE: AZN) has joined a near-$100 million series A and A+ financing round for Syneron Bio, a ...

Home to 4.8 billion people or 60 percent of the world’s population, Asia accounts for 50 percent of the global cancer ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

AstraZeneca's baxdrostat heads into FDA review after Phase 3 data showed strong blood pressure reductions in adults with hard ...